Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Pheosia gnoma

Project description:Pheosia gnoma overview

| PRJNA724757 | ENA

ilPheGnom1 alternate haplotype

Project description:Pheosia gnoma (lesser swallow prominent) genome assembly, ilPheGnom1, alternate haplotype

| PRJEB44004 | ENA